Blood purification could tackle COVID-19?

Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamada, Hiroyuki, Ohtsuru, Shigeru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665322/
https://www.ncbi.nlm.nih.gov/pubmed/34895343
http://dx.doi.org/10.1186/s40560-021-00586-0
_version_ 1784613984105660416
author Yamada, Hiroyuki
Ohtsuru, Shigeru
author_facet Yamada, Hiroyuki
Ohtsuru, Shigeru
author_sort Yamada, Hiroyuki
collection PubMed
description Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its technique also has an enormous possibility of treating severe COVID-19 in managing inflammatory cytokines and coagulopathy. Recent clinical studies have revealed the positive clinical effect of therapeutic plasma exchange. Other studies have also indicated the considerable potential of other blood purification techniques, such as Cytosorb, AN69 surface-treated membrane, and polymyxin b hemoperfusion. Further research is needed to elucidate the actual effects of these applications.
format Online
Article
Text
id pubmed-8665322
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86653222021-12-13 Blood purification could tackle COVID-19? Yamada, Hiroyuki Ohtsuru, Shigeru J Intensive Care Commentary Coronavirus disease 2019 (COVID-19) threatened human lives worldwide since first reported. The current challenge for global intensivists is to establish an effective treatment for severe COVID-19. Blood purification has been applied to the treatment of various critical illnesses. Theoretically, its technique also has an enormous possibility of treating severe COVID-19 in managing inflammatory cytokines and coagulopathy. Recent clinical studies have revealed the positive clinical effect of therapeutic plasma exchange. Other studies have also indicated the considerable potential of other blood purification techniques, such as Cytosorb, AN69 surface-treated membrane, and polymyxin b hemoperfusion. Further research is needed to elucidate the actual effects of these applications. BioMed Central 2021-12-11 /pmc/articles/PMC8665322/ /pubmed/34895343 http://dx.doi.org/10.1186/s40560-021-00586-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Commentary
Yamada, Hiroyuki
Ohtsuru, Shigeru
Blood purification could tackle COVID-19?
title Blood purification could tackle COVID-19?
title_full Blood purification could tackle COVID-19?
title_fullStr Blood purification could tackle COVID-19?
title_full_unstemmed Blood purification could tackle COVID-19?
title_short Blood purification could tackle COVID-19?
title_sort blood purification could tackle covid-19?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8665322/
https://www.ncbi.nlm.nih.gov/pubmed/34895343
http://dx.doi.org/10.1186/s40560-021-00586-0
work_keys_str_mv AT yamadahiroyuki bloodpurificationcouldtacklecovid19
AT ohtsurushigeru bloodpurificationcouldtacklecovid19

Ejemplares similares